During the past decade, Hospital Nacional Cayetano Heredia conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 13 clinical trials were completed, i.e. on average, 43.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 11 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nacional Cayetano Heredia" #1 sponsor was "Universidad Peruana Cayetano Heredia" with 13 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Mallinckrodt" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nacional Cayetano Heredia" #1 collaborator was "Johns Hopkins University" with 2 trials as a collaborator, "American Thoracic Society" with 1 trials as a collaborator, "Asociacion Benefica Prisma" with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator and "Barcelona Institute for Global Health" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nacional Cayetano Heredia" are "HIV Infections" (3 trials), "Lupus Nephritis" (3 trials), "Covid19" (2 trials), "Neurocysticercosis" (2 trials) and "SARS-CoV-2" (2 trials). Many other conditions were trialed in "Hospital Nacional Cayetano Heredia" in a lesser frequency.

Most popular intervention types in "Hospital Nacional Cayetano Heredia" are "Drug" (28 trials), "Behavioral" (4 trials), "Biological" (4 trials), "Other" (4 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Atezolizumab" (3 trials), "Maltodextrin" (3 trials), "Prednisone" (3 trials) and "Atazanavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nacional Cayetano Heredia" are 36 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Nacional Cayetano Heredia". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Hospital Nacional Cayetano Heredia, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nacional Cayetano Heredia, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".